ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-881 Cr | ₹1,380 Cr | ₹688 Cr | ₹-45 Cr | ₹-82 Cr |
What is the latest Cash Flow from Financing Activities ratio of ERIS LIFESCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-881 Cr |
Mar2024 | ₹1,380 Cr |
Mar2023 | ₹688 Cr |
Mar2022 | ₹-45 Cr |
Mar2021 | ₹-82 Cr |
How is Cash Flow from Financing Activities of ERIS LIFESCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-881 Cr | Negative | |
Mar2024 | ₹1,380 Cr | 100.53 | |
Mar2023 | ₹688 Cr | Positive | |
Mar2022 | ₹-45 Cr | Negative | |
Mar2021 | ₹-82 Cr | - |
Compare Cash Flow from Financing Activities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹23,338.6 Cr | -1.2% | -4.3% | 68.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | -1.2% |
-4.3% |
68.3% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses